20 products were found matching your search for Hepatitis B in 4 shops:

Toby K. Eisenstein Symposium Committee Chairperson Temple University School of Medicine Philadelphia, Pennsylvania 19140 This symposium is the thirteenth biennial clinical microbiology program sponsored by the Eastern Pennsylvania Branch of the American Society for Microbiology in cooperation with the Philadelphia area medical schools and the Bureau of Laboratories of the Pennsylvania Department of Health. This year a generous contribution from Merck, Sharp and Dohme has helped to make the program a reality. The subject matter for this symposium represents an attractive spectrum of medical, biological and molecular approaches to the practical solution of a public health prob1em--name1y, prevention of infection with the hepatitis B virus. The symposium may be unique in that it focuses on a product which was first marketed less than three months ago, but included in the program are presen­ tations on two new approaches to hepatitis B vaccine production which may replace the one which is newly unveiled. The rapidity of progress in our present era of biological research is indeed astonishing.

This text provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for students, clinicians, and researchers with an interest in hepatitis B.  The book reviews new data about basic and translational science including the viral life cycle, the immunopathogenesis of virus induced chronic hepatitis, the mechanism of virus induced liver cancer, and their potential applications for the clinical management of patients. The clinical aspects of this chronic viral infection are reviewed in detail with important chapters on the global epidemiology, the natural history of the disease, co-infections with its satellite virus HDV or HIV, and management of special patient populations. A major emphasis is made on the management of antiviral therapy and the recent international guidelines for the treatment of hepatitis B. Finally, the book reviews the current state of the art regarding immunoprophylaxis to prevent the spread of the virus and its major clinical consequences. The new advances and perspectives in the development of improved antiviral treatments are also discussed.Hepatitis B Virus in Human Diseases will serve as a very useful resource for students, physicians and researchers dealing with, and interested in, this challenging chronic viral infection.  It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts.  All chapters are written by experts in their fields and include the most up to date scientific and clinical information.

About 375 million people are infected with the hepatitis B virus. It has killed more people than AIDS and also causes millions of cases of liver cancer. The discovery of this deadly virus and the vaccine against it--a vaccine that is sharply decreasing the infection rate worldwide and is probably the first effective cancer vaccine--was one of the great triumphs of twentieth-century medicine. And it almost didn't happen. With wit and insight, this scientific memoir and story of discovery describes how Baruch Blumberg and a team of researchers found a virus they were not looking for and created a vaccine for a disease they previously knew little about--work that took the author around the world and won him the Nobel Prize. Blumberg and his collaborators were investigating relationships between gene distribution and disease susceptibility, research that was yielding interesting data but no real breakthroughs. Many viewed their work as more field trip than science. But, through decades of hard work and investigative twists and turns, their pursuit led to the hepatitis B antigen, the elusive virus itself, and, ultimately, the vaccine. As he takes the reader through the detective work that culminated in his incredible discovery, the author recounts with immediacy exciting moments in the lab and in the field--from a hair-raising flight to Africa to an unpleasant encounter with Alaskan sled dogs. The hepatitis B story is more than a fascinating chronicle of a major discovery. What Blumberg followed to the virus was a trail of remarkable "accidents" that happen when scientists seek answers to interesting questions. Those events, combined with the investigator's determined persistence, resulted in studies that generated a pharmaceutical industry, have far-flung public-health applications, and saved millions of lives.

Toby K. Eisenstein Symposium Committee Chairperson Temple University School of Medicine Philadelphia, Pennsylvania 19140 This symposium is the thirteenth biennial clinical microbiology program sponsored by the Eastern Pennsylvania Branch of the American Society for Microbiology in cooperation with the Philadelphia area medical schools and the Bureau of Laboratories of the Pennsylvania Department of Health. This year a generous contribution from Merck, Sharp and Dohme has helped to make the program a reality. The subject matter for this symposium represents an attractive spectrum of medical, biological and molecular approaches to the practical solution of a public health prob1em--name1y, prevention of infection with the hepatitis B virus. The symposium may be unique in that it focuses on a product which was first marketed less than three months ago, but included in the program are presen­ tations on two new approaches to hepatitis B vaccine production which may replace the one which is newly unveiled. The rapidity of progress in our present era of biological research is indeed astonishing.

In shrink wrap. Looks like an interesting title!

Hardcover and dust jacket. Good binding and cover. Light wear. Clean, unmarked pages.

Does your child need hepatitis B vaccine? How safe is it? When Your Doctor Is Wrong... scrutinizes reportable data on the virus and the vaccine as it follows one child through the terrible maze of adversely reacting to this shot. His recovery is a

Disinfectant/cleaner is proven effective against Hepatitis B, TB, HIV and a broad range of viruses, bacteria, fungi, mold and mildew. Noncaustic formula is safe on most inanimate surfaces. Liquid disinfectant/cleaner comes in a one gallon container and can be used in an ultrasonic cleaner. It is strong enough to kill on contact yet is nontoxic.

Clorox Clean-Up CloroxPro Disinfectant Cleaner with Bleach is a powerful, one-step cleaner, disinfectant and stain remover. It eliminates odors caused by bacteria, mold and mildew and kills 99.9 percent of germs including staphylococcus aureus, HIV type 1, norovirus, hepatitis B and C, salmonella enterica, pseudomonas aeruginosa and rhinovirus on hard, nonporous surfaces. Clean and disinfect confidently with the power of Clorox Bleach. Great for high traffic areas, this cleaner is perfect for use in offices, daycare centers, restaurants, schools and other commercial facilities.

CloroxPro Disinfecting Bio Stain and Odor Remover is perfect for disinfecting and removing the toughest odors and stains in one step. This bleach-free stain and odor remover uses hydrogen peroxide technology to kill HIV, herpes and flu virus in 30 seconds, kills hepatitis B and hepatitis C in 1 minute, and kills norovirus, E. coli, Salmonella and MRSA in 5 minutes. It also kills odor-causing bacteria on hard nonporous surfaces. Compliant with OSHA Bloodborne pathogens standard, this stain remover works great on stains from blood, feces, vomit, sweat, saliva and urine. Versatile disinfectant can be used to clean many different hard and soft surfaces such as walls, tile, grout, concrete, carpet, fabrics, upholstery, toilets, countertops and mattresses. It can even be used as a pre-treatment for laundry. It is designed for easy refilling to meet needs of heavy users. It is deal for hotels, care centers, schools, offices, restaurants and other commercial facilities. Packaging may vary.

Neutral disinfectant cleaner delivers outstanding cleaning and broad-spectrum disinfecting in one step. It is also EPA-registered, hospital-grade and quaternary-based. The lemon-scented disinfectant/cleaner with a neutral pH kills HIV-1, Hepatitis B virus, MRSA, MRSA-CA, E-coli and numerous other microorganisms. As staphylocidal, bactericidal, mildewstatic, pseudomonacidal, salmoneliacidal, fungicidal and virucidal, Citra Cide is ideal for healthcare, school, institutions, restroom sanitation, general cleaning and disinfecting around office buildings. It uses a 2 oz. per gallon dilution.

Disinfectant/cleaner is proven effective against Hepatitis B, TB, HIV and a broad range of viruses, bacteria, fungi, mold and mildew. Noncaustic formula is safe on most inanimate surfaces. Liquid disinfectant/cleaner comes in a one gallon container and can be used in an ultrasonic cleaner. It is strong enough to kill on contact yet is nontoxic.

CloroxPro Disinfecting Bio Stain and Odor Remover is perfect for disinfecting and removing the toughest odors and stains in one step. This bleach-free stain and odor remover uses hydrogen peroxide technology to kill HIV, herpes and flu virus in 30 seconds, kills hepatitis B and hepatitis C in 1 minute, and kills norovirus, E. coli, Salmonella and MRSA in 5 minutes. It also kills odor-causing bacteria on hard nonporous surfaces. Compliant with OSHA Bloodborne pathogens standard, this stain remover works great on stains from blood, feces, vomit, sweat, saliva and urine. Versatile disinfectant can be used to clean many different hard and soft surfaces such as walls, tile, grout, concrete, carpet, fabrics, upholstery, toilets, countertops and mattresses. It can even be used as a pre-treatment for laundry. It is designed for easy refilling to meet needs of heavy users. It is deal for hotels, care centers, schools, offices, restaurants and other commercial facilities. Packaging may vary.

CloroxPro Disinfecting Bio Stain & Odor Remover disinfects and removes the toughest odors and stains in one step. This bleach free stain and odor remover uses hydrogen peroxide technology to kill HIV, herpes, and flu virus in 30 seconds, kills hepatitis B and hepatitis C in one minute, and kills norovirus, E. coli, Salmonella and MRSA in five minutes. It meets EPA criteria for use against SARS-CoV-2, the virus that causes COVID-19. Compliant with OSHA Bloodborne pathogens standard, Disinfecting Bio Stain and Odor Remover works on stains from blood, feces, vomit, sweat, saliva, and urine. This versatile disinfectant can be used to clean many different hard and soft surfaces such as walls, tile, grout, concrete, carpet, fabrics, upholstery, toilets, counter tops, mattresses, and it can even be used as a pre-treatment for laundry. Ideal for hotels, care centers, schools, offices, restaurants and other commercial facilities. CloroxPro, where clean means everything. Packaging may vary.

How crucial it is in our modern world to prioritize safety when dealing with potential exposure to HIV, Hepatitis B, and other blood-borne diseases. Sirchie's clear plastic evidence collection tubes, measuring 1-5/16x8", are designed specifically to safeguard those involved in the evidence collection process. This set of 12 ECT1 tubes is meticulously crafted to secure sharp objects, including syringes, ensuring their immobilization during handling and transportation. Each tube features an ethafoam stopper, offering additional security for objects up to 8" in length and 1-5/16" in diameter, with a wall thickness of 0.030". These evidence collection tubes are not just tools, but a vital part of maintaining health and safety in the face of potential biohazard risks.

Does your child need hepatitis B vaccine? How safe is it? When Your Doctor Is Wrong... scrutinizes reportable data on the virus and the vaccine as it follows one child through the terrible maze of adversely reacting to this shot. His recovery is a

Antiviral drug development has led to significant advances in the control of globally prevalent viral infections by the hepatitis C (HCV) and the human immunodeficiency viruses. Nonetheless, there are current gaps in the armamentarium against global viral infections due to some herpes viruses, the hepatitis B virus, and the deadly filovirus Ebola and arenavirus Tacaribe responsible of outbreaks of hemorrhagic fever in emerging countries. Arbidol (ARB) is a cost-effective antiviral with broad-spectrum activity, administered for decades in Russia and China against flu. We showed that ARB inhibits HCV infection, and has potent antiviral activity against the Ebola, Tacaribe, hepatitis B and human herpes-8 viruses. Since these viruses have divergent life cycles, we posit that ARB may exhibit varied modes of action against different viruses. Careful dissection of molecular mechanisms of action of ARB against HCV and the Ebola virus revealed that ARB blocked viral entry. ARB might, therefore, constitute a pharmacological approach against globally prevalent viruses, and an affordable molecule for emerging countries in urgent need for effective antiviral therapies.

In a family study of breast cancer, epidemiologists in Southern California increase the power for detecting a gene-environment interaction. In Gambia, a study helps a vaccination program reduce the incidence of Hepatitis B carriage. Archaeologists in Austria place a Bronze Age site in its true temporal location on the calendar scale. And in France, researchers map a rare disease with relatively little variation.Each of these studies applied Markov chain Monte Carlo methods to produce more accurate and inclusive results. General state-space Markov chain theory has seen several developments that have made it both more accessible and more powerful to the general statistician. Markov Chain Monte Carlo in Practice introduces MCMC methods and their applications, providing some theoretical background as well. The authors are researchers who have made key contributions in the recent development of MCMC methodology and its application. Considering the broad audience, the editors emphasize practice rather than theory, keeping the technical content to a minimum. The examples range from the simplest application, Gibbs sampling, to more complex applications. The first chapter contains enough information to allow the reader to start applying MCMC in a basic way. The following chapters cover main issues, important concepts and results, techniques for implementing MCMC, improving its performance, assessing model adequacy, choosing between models, and applications and their domains.Markov Chain Monte Carlo in Practice is a thorough, clear introduction to the methodology and applications of this simple idea with enormous potential. It shows the importance of MCMC in real applications, such as archaeology, astronomy, biostatistics, genetics, epidemiology, and image analysis, and provides an excellent base for MCMC to be applied to other fields as well.

The Vaccine Safety Manual (new, updated 2012 edition) is the worlds most complete guide to immunization risks and protection. It includes pertinent information on every major vaccine: polio, tetanus, MMR, hepatitis A, B, HPV (cervical cancer), Hib, Flu, chickenpox, shingles, rotavirus, pneumococcal, meningococcal, RSV, DTaP, anthrax, smallpox, TB, and more. All of the information, including detailed vaccine safety and efficacy data, is written in an easy-to-understand format, yet includes more than 1,000 scientific citations. More than 100 charts, tables, graphs and illustrations supplement the text. This encyclopedic health manual is an important addition to every family's home library and will be referred to again and again.

In a family study of breast cancer, epidemiologists in Southern California increase the power for detecting a gene-environment interaction. In Gambia, a study helps a vaccination program reduce the incidence of Hepatitis B carriage. Archaeologists in Austria place a Bronze Age site in its true temporal location on the calendar scale. And in France, researchers map a rare disease with relatively little variation.Each of these studies applied Markov chain Monte Carlo methods to produce more accurate and inclusive results. General state-space Markov chain theory has seen several developments that have made it both more accessible and more powerful to the general statistician. Markov Chain Monte Carlo in Practice introduces MCMC methods and their applications, providing some theoretical background as well. The authors are researchers who have made key contributions in the recent development of MCMC methodology and its application. Considering the broad audience, the editors emphasize practice rather than theory, keeping the technical content to a minimum. The examples range from the simplest application, Gibbs sampling, to more complex applications. The first chapter contains enough information to allow the reader to start applying MCMC in a basic way. The following chapters cover main issues, important concepts and results, techniques for implementing MCMC, improving its performance, assessing model adequacy, choosing between models, and applications and their domains.Markov Chain Monte Carlo in Practice is a thorough, clear introduction to the methodology and applications of this simple idea with enormous potential. It shows the importance of MCMC in real applications, such as archaeology, astronomy, biostatistics, genetics, epidemiology, and image analysis, and provides an excellent base for MCMC to be applied to other fields as well.